Study to Evaluate the Safety, Tolerability, and Efficacy of Cilofexor in Adults With Primary Sclerosing Cholangitis Without Cirrhosis

Completed · Phase 2 · Has a placebo group

Conditions studied: Primary Sclerosing Cholangitis

In brief

The primary objective of this study is to evaluate the safety and tolerability of cilofexor in adults with primary sclerosing cholangitis (PSC).

Key facts

Study ID
NCT02943460
Run by
Gilead Sciences
People needed
52
Starts
2016-11-29
Expected to finish
2020-05-18
Last updated by the study team
2021-06-07

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.